[144] Jazz Pharmaceuticals, Inc. SEC Filing
Jazz Pharmaceuticals (JAZZ) submitted a Form 144 reporting a proposed sale of 3,731 shares of common stock through ETRADE Financial Corporation on 08/08/2025 with an aggregate market value of $417,872. The filing shows the shares were acquired on 08/07/2025 through restricted stock vesting and were granted as compensation. The form states there were no securities sold in the past three months by the selling person and includes the seller's certification that they are not aware of undisclosed material adverse information about the issuer. The shares represent a very small fraction of the 60,658,809 shares outstanding.
Jazz Pharmaceuticals (JAZZ) ha presentato un Form 144 segnalando la proposta di vendita di 3,731 azioni ordinarie tramite ETRADE Financial Corporation il 08/08/2025, per un valore complessivo di $417,872. Il documento indica che le azioni sono state acquisite il 08/07/2025 tramite restricted stock vesting e sono state conferite come compenso. Il modulo dichiara che la persona venditrice non ha venduto titoli nei tre mesi precedenti e include la certificazione di non essere a conoscenza di informazioni negative materiali non divulgate sull'emittente. Le azioni rappresentano una frazione molto ridotta delle 60,658,809 azioni in circolazione.
Jazz Pharmaceuticals (JAZZ) present贸 un Form 144 notificando una propuesta de venta de 3,731 acciones ordinarias a trav茅s de ETRADE Financial Corporation el 08/08/2025, por un valor agregado de $417,872. La presentaci贸n indica que las acciones se adquirieron el 08/07/2025 mediante restricted stock vesting y se otorgaron como 肠辞尘辫别苍蝉补肠颈贸苍. El formulario declara que la persona vendedora no ha vendido valores en los 煤ltimos tres meses e incluye su certificaci贸n de no tener conocimiento de informaci贸n adversa material no divulgada sobre el emisor. Las acciones representan una fracci贸n muy peque帽a de las 60,658,809 acciones en circulaci贸n.
Jazz Pharmaceuticals (JAZZ)电� Form 144 鞏戩嫕鞚� 鞝滌稖頃橃棳 3,731欤�鞚� 氤错喌欤茧ゼ ETRADE Financial Corporation鞚� 韱淀暣 08/08/2025鞐� 毵る弰頃� 鞓堨爼鞛勳潉 氤搓碃頄堨溂氅� 齑� 鞁滉皜 臧�旃樀鐢 $417,872鞛呺媹雼�. 鞝滌稖靹滊鞐� 霐半ゴ氅� 頃措嫻 欤检嫕鞚� 08/07/2025鞐� restricted stock vesting(鞝滍暅欤检嫕 氩犾姢韺�)鞙茧 旆摑霅橃棃瓿� 氤挫儊鞙茧 攵�鞐悩鞐堨姷雼堧嫟. 鞏戩嫕鞐惖鐢 韺愲Г鞚胳澊 歆�雮� 3臧滌洈 霃欖晥 歃濌秾鞚� 韺愲Г頃橃 鞎婌晿雼さ鐢 鞝愱臣 氚滍枆須岇偓鞐� 雽�頃� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岅碃 鞛堨 鞎婋嫟电� 鞚胳鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� 鞙犿喌欤检嫕靾� 60,658,809欤� 欷� 毵れ毎 鞛戩潃 牍勳鞚� 彀頃╇媹雼�.
Jazz Pharmaceuticals (JAZZ) a d茅pos茅 un Form 144 signalant une vente propos茅e de 3,731 actions ordinaires via ETRADE Financial Corporation le 08/08/2025, pour une valeur totale de $417,872. Le d茅p么t indique que les actions ont 茅t茅 acquises le 08/07/2025 par restricted stock vesting et ont 茅t茅 attribu茅es en tant que 谤茅尘耻苍茅谤补迟颈辞苍. Le formulaire pr茅cise que la personne vendeuse n'a pas vendu de titres au cours des trois derniers mois et inclut sa certification qu'elle n'a pas connaissance d'informations d茅favorables majeures non divulgu茅es concernant l'茅metteur. Ces actions repr茅sentent une tr猫s faible fraction des 60,658,809 actions en circulation.
Jazz Pharmaceuticals (JAZZ) hat ein Form 144 eingereicht und eine geplante Ver盲u脽erung von 3,731 Aktien des Stammkapitals 眉ber ETRADE Financial Corporation am 08/08/2025 gemeldet, mit einem aggregierten Marktwert von $417,872. Die Meldung weist aus, dass die Aktien am 08/07/2025 durch restricted stock vesting erworben und als 痴别谤驳眉迟耻苍驳 gew盲hrt wurden. Das Formular besagt, dass die verkaufende Person in den letzten drei Monaten keine Wertpapiere verkauft hat und enth盲lt deren Bescheinigung, dass ihr keine nicht offengelegten, wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt sind. Die Aktien stellen einen sehr kleinen Anteil an den 60,658,809 ausstehenden Aktien dar.
- None.
- None.
Insights
TL;DR: Routine insider sale from recent restricted stock vesting; size is immaterial to company capitalization.
The filing documents a proposed sale of 3,731 shares acquired through restricted stock vesting and classified as compensation, to be executed through ETRADE Financial Corporation on 08/08/2025, at an aggregate value of $417,872. Given the 60,658,809 shares outstanding, the position is negligible relative to total equity, suggesting limited market impact. The disclosure that there were no sales in the prior three months and the signer鈥檚 certification regarding undisclosed material information are standard Form 144 elements. This notice does not present new operational or financial information about the issuer.
TL;DR: Filing reflects routine compensation-related vesting and planned sale; governance implications are standard and non-material.
The transaction is recorded as restricted stock vesting with payment characterized as compensation, indicating the shares stem from employee or executive equity awards rather than an open-market purchase. The use of a broker and the explicit representation about undisclosed material adverse information align with compliance expectations for insider dispositions. There are no disclosures here of unusual acceleration, related-party issues, or clustered prior sales that would raise governance concerns.
Jazz Pharmaceuticals (JAZZ) ha presentato un Form 144 segnalando la proposta di vendita di 3,731 azioni ordinarie tramite ETRADE Financial Corporation il 08/08/2025, per un valore complessivo di $417,872. Il documento indica che le azioni sono state acquisite il 08/07/2025 tramite restricted stock vesting e sono state conferite come compenso. Il modulo dichiara che la persona venditrice non ha venduto titoli nei tre mesi precedenti e include la certificazione di non essere a conoscenza di informazioni negative materiali non divulgate sull'emittente. Le azioni rappresentano una frazione molto ridotta delle 60,658,809 azioni in circolazione.
Jazz Pharmaceuticals (JAZZ) present贸 un Form 144 notificando una propuesta de venta de 3,731 acciones ordinarias a trav茅s de ETRADE Financial Corporation el 08/08/2025, por un valor agregado de $417,872. La presentaci贸n indica que las acciones se adquirieron el 08/07/2025 mediante restricted stock vesting y se otorgaron como 肠辞尘辫别苍蝉补肠颈贸苍. El formulario declara que la persona vendedora no ha vendido valores en los 煤ltimos tres meses e incluye su certificaci贸n de no tener conocimiento de informaci贸n adversa material no divulgada sobre el emisor. Las acciones representan una fracci贸n muy peque帽a de las 60,658,809 acciones en circulaci贸n.
Jazz Pharmaceuticals (JAZZ)电� Form 144 鞏戩嫕鞚� 鞝滌稖頃橃棳 3,731欤�鞚� 氤错喌欤茧ゼ ETRADE Financial Corporation鞚� 韱淀暣 08/08/2025鞐� 毵る弰頃� 鞓堨爼鞛勳潉 氤搓碃頄堨溂氅� 齑� 鞁滉皜 臧�旃樀鐢 $417,872鞛呺媹雼�. 鞝滌稖靹滊鞐� 霐半ゴ氅� 頃措嫻 欤检嫕鞚� 08/07/2025鞐� restricted stock vesting(鞝滍暅欤检嫕 氩犾姢韺�)鞙茧 旆摑霅橃棃瓿� 氤挫儊鞙茧 攵�鞐悩鞐堨姷雼堧嫟. 鞏戩嫕鞐惖鐢 韺愲Г鞚胳澊 歆�雮� 3臧滌洈 霃欖晥 歃濌秾鞚� 韺愲Г頃橃 鞎婌晿雼さ鐢 鞝愱臣 氚滍枆須岇偓鞐� 雽�頃� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒毳� 鞎岅碃 鞛堨 鞎婋嫟电� 鞚胳鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 欤检嫕鞚� 鞙犿喌欤检嫕靾� 60,658,809欤� 欷� 毵れ毎 鞛戩潃 牍勳鞚� 彀頃╇媹雼�.
Jazz Pharmaceuticals (JAZZ) a d茅pos茅 un Form 144 signalant une vente propos茅e de 3,731 actions ordinaires via ETRADE Financial Corporation le 08/08/2025, pour une valeur totale de $417,872. Le d茅p么t indique que les actions ont 茅t茅 acquises le 08/07/2025 par restricted stock vesting et ont 茅t茅 attribu茅es en tant que 谤茅尘耻苍茅谤补迟颈辞苍. Le formulaire pr茅cise que la personne vendeuse n'a pas vendu de titres au cours des trois derniers mois et inclut sa certification qu'elle n'a pas connaissance d'informations d茅favorables majeures non divulgu茅es concernant l'茅metteur. Ces actions repr茅sentent une tr猫s faible fraction des 60,658,809 actions en circulation.
Jazz Pharmaceuticals (JAZZ) hat ein Form 144 eingereicht und eine geplante Ver盲u脽erung von 3,731 Aktien des Stammkapitals 眉ber ETRADE Financial Corporation am 08/08/2025 gemeldet, mit einem aggregierten Marktwert von $417,872. Die Meldung weist aus, dass die Aktien am 08/07/2025 durch restricted stock vesting erworben und als 痴别谤驳眉迟耻苍驳 gew盲hrt wurden. Das Formular besagt, dass die verkaufende Person in den letzten drei Monaten keine Wertpapiere verkauft hat und enth盲lt deren Bescheinigung, dass ihr keine nicht offengelegten, wesentlichen nachteiligen Informationen 眉ber den Emittenten bekannt sind. Die Aktien stellen einen sehr kleinen Anteil an den 60,658,809 ausstehenden Aktien dar.
FAQ
What does the Form 144 filed for Jazz Pharmaceuticals (JAZZ) report?
How were the 3,731 JAZZ shares acquired?
Does the filing show prior sales by the seller in the last three months?
Who is the broker handling the sale in the Form 144?
How large is the proposed sale relative to outstanding shares?
